Skip to main content

Trinity College Dublin, The University of Dublin

Trinity Menu Trinity Search

You are here Media Centre > News

  • New machine-learning technique for classifying key immune cells .
  • Many TBSI amongst the eleven TCD researchers who have been awarded €4 million to tackle global health challenges .
  • Scientists create luminescent gels with multitude of applications from counterfeiting to bio-sensing .
  • Centre for Biomedical Engineering at TBSI: Prof Michael Monaghan, Dr Matteo Solazzo and team have developed a low cost prototype wearable sensor for health care applications .
  • TBSI professor Richard Porter links with Artelo to investigate Fatty Acid Binding Protein inhibition in cancer.
  • The immunologists, led by Dr Nigel Stevenson, Assistant Professor in Viral Immunology at TBSI, have discovered how SARS and MERS proteins block the induction of antiviral proteins, which prevents us from mounting a strong innate immune response against infection .
  • Discovery of new immune process that regulates inflammation in human fat may help manage obesity. TCD Comms .
  • Researchers discover new therapeutic target for severe asthma, lead investigator Luke O’Neill .
  • North-South Cancer Liquid Biopsies Research Programme. Irish Times.
  • Tánaiste Leo Varadkar launches Irish-led €10 million project to deliver ‘precision medicine’ for Motor Neuron Disease .
  • Scientists discover how key protein drives our immune response against viruses .
  • Why do we forget? New theory proposes ‘forgetting’ is actually a form of learning .
  • TBSI host Conference, 10 November,
  • Scientists at TBSI discover new ways to block inflammatory cells implicated in a suite of diseases.
  • Initiate and Trinity COVID19 project are collaborating for EU Researchers Night.
  • Irish scientists among global group hunting for genetic explanation to COVID-19 resistance.
  • Quantum chemists conjure recipe to turn gold, silver and copper into vessels of green energy.
  • Scientists based in TCD/TBSI are researching plants and microbes in soil and water for pharmaceuticals.
  • Scientists blueprint bacterial enzyme believed to play “stealthy” role in suppressing immune response.
  • New approach to molecular drug design yields highly promising bladder cancer drug candidate following successful conclusion of Phase I/II clinical trials
  • Immunologists discover new trick used by MRSA superbug.
  • Dr David Finlay teams up with ONK Therapeutics to seek improved cancer therapies.
  • 6 Irish start-ups taking to the virtual stage at BioEquity Europe. Great to see so many from TBSI involved.
  • Three Trinity researchers win European Research Council Advanced Grants.
  • Researchers Investigate treatment of cancer cachexia in collaboration with Artelo Biosciences.
  • Two new potential therapeutic targets for rheumatoid arthritis.
  • Science Foundation Ireland 2020 Science Awards recognise key leaders in the Irish Research Community.
  • Is reaching zero COVID-19 possible?.
  • Landmark deal for UQ-Trinity inflammation startup.